Barclays’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,000
Closed -$466K 5432
2024
Q3
$466K Sell
2,000
-2,100
-51% -$431K ﹤0.01% 3826
2024
Q2
$827K Buy
4,100
+2,000
+95% +$360K ﹤0.01% 2717
2024
Q1
$360K Hold
2,100
﹤0.01% 3787
2023
Q4
$456K Buy
+2,100
New +$360K ﹤0.01% 3936
2022
Q3
Sell
-37,600
Closed -$8.19M 5059
2022
Q2
$8.19M Buy
+37,600
New +$8.55M 0.01% 1094

Other funds holding PODD

Barclays's PODD Position: Q1 2026 in Review

Barclays reduced its Insulet (PODD) stake by 43% in Q1 2026, selling an estimated $24.5M and leaving 128,512 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #975.

Barclays first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $73.1M in Q1 2024. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Barclays held 128,512 shares of Insulet worth $27M as of Q1 2026.
  • Barclays sold 97,377 Insulet shares in Q1 2026, an estimated $24.5M.
  • Insulet made up 0.01% of Barclays's portfolio in Q1 2026, its #975 holding.
  • Barclays first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Insulet position peaked at $73.1M in Q1 2024.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.